FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
HealthDay on MSN6 天
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...
Endocrinology Advisor1 天
Gemtesa Approved for Men With OAB Symptoms Receiving BPH Treatment
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Too Old to Operate6 天
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
THURSDAY, Jan. 2, 2025 (HealthDay News) — Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy ...
pharmaphorum3 天
FDA approves Adstiladrin as first gene therapy for NMIBC
According to the Centers for Disease Control and Prevention, about 57,000 men and ... adjuvant treatment of some patients with urothelial carcinoma (UC), the most common form of bladder cancer.
Medindia11 小时
Could Targeted Steam Therapy Cure Prostate Cancer?
A new clinical trial explores whether targeted steam therapy can offer a less invasive, effective treatment for prostate ...
FierceBiotech1 天
Francis Medical collects $80M to carry water vapor ablation for prostate cancer to the FDA
Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation ...
BlackDoctor2 天
Black Men: Is Cryotherapy a Viable Option for You?
While cryotherapy can be effective, it’s not the right treatment for everybody so it’s good for you to know what it entails.